ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
NCT04277221
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
118
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
BIOLOGICAL:
Autologous Dendritic Cell/Tumor Antigen, ADCTA
Sponsor
Safe Save Medical Cell Sciences & Technology Co.,Ltd.